In Korea, addressing drug audit findings involves reviewing the audit report, identifying non-compliance issues, implementing corrective actions, and documenting changes. Regulatory authorities must be notified, and follow-up audits ensure compliance. Continuous monitoring and staff training are essential to maintain adherence to regulations and prevent future discrepancies.
